The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progress...
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma: sVEGFR1, lung tumor progression and anti-angiogenics
About this item
Full title
Author / Creator
Publisher
Cancer Research UK
Journal title
Language
English
Formats
Publication information
Publisher
Cancer Research UK
Subjects
More information
Scope and Contents
Contents
BACKGROUND:While lung adenocarcinoma patients can somewhat benefit from anti-angiogenic therapies, patients with squamous cell lung carcinoma (SQLC) cannot. The reasons for this discrepancy remain largely unknown. Soluble VEGF receptor-1, namely sVEGFR1-i13, is a truncated splice variant of the cell membrane-spanning VEGFR1 that has no transmembran...
Alternative Titles
Full title
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma: sVEGFR1, lung tumor progression and anti-angiogenics
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_inserm_02345348v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02345348v1
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-018-0128-4
